Michelle Minoff

Marketing & Advertising Consultant. Guest Lecturer Baruch College. Ex-Conde Nast, WIRED, AOL,

[Michelle Minoff @mminoff]

@HadidiSamer @RahulBanerjeeMD Are any of these results changing thoughts on first lines? It seems like a logical step in HR patients.

[Michelle Minoff @mminoff]

@RahulBanerjeeMD @VincentRK @fredhutch @UWMedicine Congratulations!

[Michelle Minoff @mminoff]

@VincentRK The last 10 years has been explosive! Patients can imagine such a different path forward now. Thank you to everyone who contributed to this progress.

[Michelle Minoff @mminoff]

@RahulBanerjeeMD @Rfonsi1 Excellent and accessible content! How do these results shift thinking about first line treatment? Does first line car-t and 2nd dara + tec potentially give better OS results or does the car-t bottle neck impact decisions about possible shift in SOC?

[Michelle Minoff @mminoff]

@rajshekharucms Thanks for looking into the treatment crystal ball for a moment!

[Michelle Minoff @mminoff]

@VincentRK @ASH_hematology @szusmani Thank you for all the work you do and the information you provide here! 14:16 patients don't see a lot of news and appreciate your answers! Happy New Year!

[Michelle Minoff @mminoff]

@rajshekharucms @ASH_hematology @SLentzsch @DivayaB @columbiacancer This is such a helpful one sheeter for patients to feel confident about numerous options. Wondering how MajesTEC might change this landscape, especially for HR patients.

[Michelle Minoff @mminoff]

@VincentRK Do you suggest ongoing Dara? If not do you have a suggested endpoint?

[Michelle Minoff @mminoff]

@mcuban @TexasOncologist @TruemanBonnie1 @MsTex_as4now Thank you @mcuban! The worry associated with the high costs on life saving meds affects quality of life and mental health.

[Michelle Minoff @mminoff]

@rajshekharucms @Rfonsi1 Are the study participants all patients getting CAR-T as 4th+ line of treatment?

[Michelle Minoff @mminoff]

@VincentRK @JCO_ASCO @Myeloma_Society @IMFmyeloma @NikhilMunshiMD @mvmateos @SagarLonialMD @szusmani @NoopurRajeMD @chngwj @NBahlis @IrenemGhobrial @myelomaMD As an smm patient I have found very little information about 14:16 translocation other than it is uncommon and puts the patient in high risk category. Are any treatments more well suited to managing this particular abnormality?

[Michelle Minoff @mminoff]

@rajshekharucms @JCO_ASCO Are similar studies in the works for patients who are having CAR-T earlier in their progression? It would be interesting to compare how less pre treated patients fare in the long term using CAR-T.

[Michelle Minoff @mminoff]

@mrsscollinshhhs @henhudschools @mrsscollinshhhs Congratulations! Would love to connect before Tuesday!

[Michelle Minoff @mminoff]

@mrsscollinshhhs @henhudschools Congratulations! We still miss you!

[Michelle Minoff @mminoff]

@llsethj Good timing! Let's discuss!

[Michelle Minoff @mminoff]

@BHealy314 @VillageCroton A glorious time of year! @BHealy314 How would we go about requiring new village plantings be native to our area? Or even plantings on new multi dwelling development? Is there a process for this kind of discussion?

[John Spencer @SpencerGuard]

“Israel Implemented More Measures to Prevent Civilian Casualties Than Any Other Nation in History.” my full article @Newsweek https://t.co/wM4HvuIdGG

[Alex Vindman 🇺🇸 @AVindman]

A consistent goal of influence ops is to eliminate the idea of absolute truth & muddy the waters because for our enemy’s chaos creates opportunity. Hence, influence ops in the cyber domain are the tools of choice for illiberal regimes efforts to sow discord & create chaos.